- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: BMC Cancer 19 (2019).
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2019
- Creator
-
Krückel, Annika
Moreira, Alvaro
Fröhlich, Waltraud
Schuler, Gerold
Heinzerling, Lucie
- URN
-
urn:nbn:de:bvb:29-opus4-121474
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:45 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krückel, Annika
- Moreira, Alvaro
- Fröhlich, Waltraud
- Schuler, Gerold
- Heinzerling, Lucie
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2019
Other Objects (12)
The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B
Prognostic significance of PCNA grade in malignant melanoma
Validation of the graded prognostic assessment for Melanoma using molecular markers (Melanoma-molGPA)
Melanoma of the ear : prognostic factors and surgical strategies
Prognostic factors and medical treatments of patients with melanoma
Analysis of biomarkers in liquid biopsies for prognostic and diagnostic testing in patients with retinoblastoma and uveal melanoma
Multivariate analysis of prognostic factors in patients with nodular melanoma
Oxadiazolyl-Pyridinium as Cationic Scaffold for Fluorinated Ionic Liquid Crystals
Eosinophils as biomarker in melanoma immunotherapy and solid tumors
Extracellular vesicles as cancer liquid biopsy biomarker
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B
Prognostic significance of PCNA grade in malignant melanoma
Validation of the graded prognostic assessment for Melanoma using molecular markers (Melanoma-molGPA)
Melanoma of the ear : prognostic factors and surgical strategies
Prognostic factors and medical treatments of patients with melanoma
Analysis of biomarkers in liquid biopsies for prognostic and diagnostic testing in patients with retinoblastoma and uveal melanoma
Multivariate analysis of prognostic factors in patients with nodular melanoma
Oxadiazolyl-Pyridinium as Cationic Scaffold for Fluorinated Ionic Liquid Crystals
Eosinophils as biomarker in melanoma immunotherapy and solid tumors
Extracellular vesicles as cancer liquid biopsy biomarker
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B
Prognostic significance of PCNA grade in malignant melanoma
Validation of the graded prognostic assessment for Melanoma using molecular markers (Melanoma-molGPA)
Melanoma of the ear : prognostic factors and surgical strategies
Prognostic factors and medical treatments of patients with melanoma
Analysis of biomarkers in liquid biopsies for prognostic and diagnostic testing in patients with retinoblastoma and uveal melanoma
Multivariate analysis of prognostic factors in patients with nodular melanoma
Oxadiazolyl-Pyridinium as Cationic Scaffold for Fluorinated Ionic Liquid Crystals
Eosinophils as biomarker in melanoma immunotherapy and solid tumors
Extracellular vesicles as cancer liquid biopsy biomarker
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy